B6;129P2-Men1tm1.1Zqw/Orl

Status

Available to order

EMMA IDEM:01387
International strain nameB6;129P2-Men1tm1.1Zqw/Orl
Alternative nameMen1+/delE3
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolMen1tm1.1Zqw,
Gene/Transgene symbolMen1

Information from provider

ProviderPhilippe Bertolino
Provider affiliationLaboratoire Génétique Moléculaire, Signalisation et Cancer, CNRS, UMR5201, Universté Claude Bern
Genetic informationThe Men1 constitutively deleted allele (tm1.1Zqw) was derived from the Men1 conditionally targeted allele (tm1Zqw, see descriptions of EMMA strains EM:01384 and EM:01386) by transfection of targeted ES cells with a cre recombinase-expressing plasmid (pMC-Cre). The neo gene, TK gene, and exon 3 were therefore removed by cre-mediated recombination, resulting in the disruption of the Men1 open reading frame, which is not functional in mice.
Phenotypic informationThe Men1 null embryos are lethal at E11.5 to E13.5 and display neural tube disclosure, abnormalities in the liver and in heart development. The heterozygous Men1 mice develop hyperplastic lesions at 8 months and multiple endocrine tumours starting from 12 months.
Breeding historyThis strain is always maintained, even currently, by inbred cross (+/delE3 X +/delE3), and has never been backcrossed or outcrossed.
References
  • Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.;Bertolino Philippe, Radovanovic Ivan, Casse Huguette, Aguzzi Adriano, Wang Zhao-Qi, Zhang Chang-Xian, ;2003;Mechanisms of development;120;549-60; 12782272
  • Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.;Bertolino Philippe, Tong Wei-Min, Galendo Dominique, Wang Zhao-Qi, Zhang Chang-Xian, ;2003;Molecular endocrinology (Baltimore, Md.);17;1880-92; 12819299

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • abnormal neural tube closure / MGI
  • abnormal cell differentiation / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI

Literature references

  • Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.;Bertolino Philippe, Radovanovic Ivan, Casse Huguette, Aguzzi Adriano, Wang Zhao-Qi, Zhang Chang-Xian, ;2003;Mechanisms of development;120;549-60; 12782272
  • Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.;Bertolino Philippe, Tong Wei-Min, Galendo Dominique, Wang Zhao-Qi, Zhang Chang-Xian, ;2003;Molecular endocrinology (Baltimore, Md.);17;1880-92; 12819299

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).